Replies to post #106610 on Biotech Values

[jq1234]

I agree the threat is genuine. Investors should know about this already because Novolog patent expires next year. But it seemed they were oblivious until now. I was talking to a friend last weekend about how NVO crossed $100 a month after I sold because I thought $90 was over valued.